Loading...
Finance Manager, Entity and Financial Planning & Analysis at Abbvie
AbbvieNorth Chicago, IL, us·6h ago
SeniorFull-time
Salary Range
$66,300 - $89,700 /year
This salary is estimated based on similar roles. The actual salary may vary.
This position reports to the Director, Entity and Financial Planning & Analysis and supports key workstreams associated with AbbVie’s Quarterly Earnings Calls, Board of Directors (BOD) & Executive Leadership Team (ELT) packages, Cash Conversion Cycle (CCC) Metrics, and Entity Plan. This role liaises with multiple cross-functional stakeholders within Finance and has opportunities to interact with all levels of the organization, including senior leadership through the CFO.  
Responsibilities
• Lead the preparation of the quarterly earnings package used by AbbVie Executives / Investor Relations during earnings calls
• Assist with producing key analytics for BOD, ELT, Leadership Forum & other management packages
• Collaborate with Investor Relations to produce analytics that inform LBEs, Quarterly Flash, LRP, Plan and BOD package publications
• Support Associate Director, Entity Planning with entity forecast consolidation and modeling for Plan / LBE / LRP, including Intercompany Reconciliations, Deferred Margin analysis and Performance vs Entity reconciliation
• Compile a comprehensive monthly Executive Goal Grading Reporting Package
• Liaison with Procurement to compile a quarterly Consulting spend analysis
• Support Director, Entity and Financial Planning & Analysis in driving high visibility special project(s)
• Assignment Manager for the FDP CFP&A rotation
• Ad-hoc analysis (e.g. P&L profiles, Growth Metrics, R&D Analytics, peer comparison) as required
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
